Pregnancy outcome in anti-N-methyl-D-aspartate receptor encephalitis.

Joseph Magley, Dena Towner, Véronique Taché, Michelle L. Apperson

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis is an autoimmune disorder resulting in neurologic and psychiatric symptoms. Treatment is challenging in pregnancy, because little data exist to guide management. A 24-year-old woman with a known diagnosis of anti-NMDA receptor encephalitis using intravenous immunoglobulin therapy became pregnant. Her pregnancy was uncomplicated with no relapses. She delivered at 35 4/7 weeks of gestation after having preterm premature rupture of membranes. She had a relapse of symptoms after delivery. This patient with anti-NMDA receptor encephalitis had an uneventful pregnancy with overall good outcome; however, she experienced relapse soon after delivery. This disease may mimic other autoimmune diseases, with improvement during pregnancy and risk for relapse postpartum.

Original languageEnglish (US)
Pages (from-to)480-483
Number of pages4
JournalObstetrics and Gynecology
Volume120
Issue number2 Pt 2
StatePublished - Aug 2012

Fingerprint

Anti-N-Methyl-D-Aspartate Receptor Encephalitis
Pregnancy Outcome
Pregnancy
Recurrence
Passive Immunization
Intravenous Immunoglobulins
Neurologic Manifestations
Postpartum Period
Autoimmune Diseases
Psychiatry

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Pregnancy outcome in anti-N-methyl-D-aspartate receptor encephalitis. / Magley, Joseph; Towner, Dena; Taché, Véronique; Apperson, Michelle L.

In: Obstetrics and Gynecology, Vol. 120, No. 2 Pt 2, 08.2012, p. 480-483.

Research output: Contribution to journalArticle

@article{1164c59872ac4a29b4c663fc936f4022,
title = "Pregnancy outcome in anti-N-methyl-D-aspartate receptor encephalitis.",
abstract = "Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis is an autoimmune disorder resulting in neurologic and psychiatric symptoms. Treatment is challenging in pregnancy, because little data exist to guide management. A 24-year-old woman with a known diagnosis of anti-NMDA receptor encephalitis using intravenous immunoglobulin therapy became pregnant. Her pregnancy was uncomplicated with no relapses. She delivered at 35 4/7 weeks of gestation after having preterm premature rupture of membranes. She had a relapse of symptoms after delivery. This patient with anti-NMDA receptor encephalitis had an uneventful pregnancy with overall good outcome; however, she experienced relapse soon after delivery. This disease may mimic other autoimmune diseases, with improvement during pregnancy and risk for relapse postpartum.",
author = "Joseph Magley and Dena Towner and V{\'e}ronique Tach{\'e} and Apperson, {Michelle L.}",
year = "2012",
month = "8",
language = "English (US)",
volume = "120",
pages = "480--483",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "2 Pt 2",

}

TY - JOUR

T1 - Pregnancy outcome in anti-N-methyl-D-aspartate receptor encephalitis.

AU - Magley, Joseph

AU - Towner, Dena

AU - Taché, Véronique

AU - Apperson, Michelle L.

PY - 2012/8

Y1 - 2012/8

N2 - Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis is an autoimmune disorder resulting in neurologic and psychiatric symptoms. Treatment is challenging in pregnancy, because little data exist to guide management. A 24-year-old woman with a known diagnosis of anti-NMDA receptor encephalitis using intravenous immunoglobulin therapy became pregnant. Her pregnancy was uncomplicated with no relapses. She delivered at 35 4/7 weeks of gestation after having preterm premature rupture of membranes. She had a relapse of symptoms after delivery. This patient with anti-NMDA receptor encephalitis had an uneventful pregnancy with overall good outcome; however, she experienced relapse soon after delivery. This disease may mimic other autoimmune diseases, with improvement during pregnancy and risk for relapse postpartum.

AB - Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis is an autoimmune disorder resulting in neurologic and psychiatric symptoms. Treatment is challenging in pregnancy, because little data exist to guide management. A 24-year-old woman with a known diagnosis of anti-NMDA receptor encephalitis using intravenous immunoglobulin therapy became pregnant. Her pregnancy was uncomplicated with no relapses. She delivered at 35 4/7 weeks of gestation after having preterm premature rupture of membranes. She had a relapse of symptoms after delivery. This patient with anti-NMDA receptor encephalitis had an uneventful pregnancy with overall good outcome; however, she experienced relapse soon after delivery. This disease may mimic other autoimmune diseases, with improvement during pregnancy and risk for relapse postpartum.

UR - http://www.scopus.com/inward/record.url?scp=84867586292&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867586292&partnerID=8YFLogxK

M3 - Article

C2 - 22825272

AN - SCOPUS:84867586292

VL - 120

SP - 480

EP - 483

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 2 Pt 2

ER -